Roldán, F.L.; Lozano, J.J.; Ingelmo-Torres, M.; Carrasco, R.; DÃaz, E.; Ramirez-Backhaus, M.; Rubio, J.; Reig, O.; Alcaraz, A.; Mengual, L.;
et al. Clinicopathological and Molecular Prognostic Classifier for Intermediate/High-Risk Clear Cell Renal Cell Carcinoma. Cancers 2021, 13, 6338.
https://doi.org/10.3390/cancers13246338
AMA Style
Roldán FL, Lozano JJ, Ingelmo-Torres M, Carrasco R, DÃaz E, Ramirez-Backhaus M, Rubio J, Reig O, Alcaraz A, Mengual L,
et al. Clinicopathological and Molecular Prognostic Classifier for Intermediate/High-Risk Clear Cell Renal Cell Carcinoma. Cancers. 2021; 13(24):6338.
https://doi.org/10.3390/cancers13246338
Chicago/Turabian Style
Roldán, Fiorella L., Juan J. Lozano, Mercedes Ingelmo-Torres, Raquel Carrasco, Esther DÃaz, Miguel Ramirez-Backhaus, José Rubio, Oscar Reig, Antonio Alcaraz, Lourdes Mengual,
and et al. 2021. "Clinicopathological and Molecular Prognostic Classifier for Intermediate/High-Risk Clear Cell Renal Cell Carcinoma" Cancers 13, no. 24: 6338.
https://doi.org/10.3390/cancers13246338
APA Style
Roldán, F. L., Lozano, J. J., Ingelmo-Torres, M., Carrasco, R., DÃaz, E., Ramirez-Backhaus, M., Rubio, J., Reig, O., Alcaraz, A., Mengual, L., & Izquierdo, L.
(2021). Clinicopathological and Molecular Prognostic Classifier for Intermediate/High-Risk Clear Cell Renal Cell Carcinoma. Cancers, 13(24), 6338.
https://doi.org/10.3390/cancers13246338